Analytical Data
-
Gene name
SLC41A2
- Application
-
Alternative Names
SLC41A2；Solute carrier family 41 member 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96JW4
-
Expression Region
1-162aa
-
AA Sequence
MTNSKGRSITDKTSGGPSSGGGFVDWTLRLNTIQSDKFLNLLLSMVPVIYQKNQEDRHKKANGIWQDGLSTAVQTFSNRSEQHMEYHSFSEQSFHANNGHASSSCSQKYDDYANYNYCDGRETSETTAMLQDEDISSDGDEDAIVEVTPKLPKESSGIMALQ
-
Molecular Weight
22.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC41A2, a member of the solute carrier family, plays a crucial role in cellular transport processes, particularly in the movement of magnesium and other ions across membranes. Recent studies have highlighted its significance in maintaining cellular ion homeostasis, which is vital for various physiological functions, including muscle contraction, nerve transmission, and enzyme activity regulation. Dysregulation of SLC41A2 has been implicated in several health conditions, including neurodevelopmental disorders and metabolic syndromes, drawing attention to its potential as a therapeutic target. The production of recombinant SLC41A2 protein in model systems, such as bacteria or yeast, facilitates detailed functional characterization and pharmacological studies. This research aims to elucidate the protein’s structural and dynamic properties, uncover its mechanisms of action, and explore its interactions with other cellular components. Understanding SLC41A2 at a molecular level may reveal valuable insights for developing targeted therapies to address related pathologies and improve our comprehension of ion transport mechanisms within cells.
